openPR Logo
Press release

Global Analysis of Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market - Industry Analysis, Size, Share, Growth, Trends and Forecast

04-07-2017 04:05 PM CET | Health & Medicine

Press release from: Latest Research Report - MRRSE

MRRSE

MRRSE

Albany, New York, April 7, 2017: Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled ‘Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast . Sulfonamides are a group of drugs that are derived from sulfanilamide, a sulfur containing compound. Sulfonamides are the most commonly used antibiotics around the world and have been in clinical use since 1968. Sulfonamides, also known as anti-metabolites and sulfa drugs act by inhibiting the folic acid synthesis pathway in a bacterial cell. These antibiotics are considered as selective targeted option since human do not synthesize folic acid, but a bacterial cell requires it for the synthesis of adenine and thiamine derivatives of its nucleic acid. These drugs are bacteriostatic in nature and are often utilized in the systemic treatment of acute, uncomplicated urinary tract infections and respiratory upper tract infections. With a broad spectrum of activity, these drugs are also utilized to treat various other bacterial infections like enteritis, chronic bronchitis in adults, otitis media in children and traveler’s diarrhea. The leading drugs in this segment are sulfamethoxazole, sulfisomidine, sulfadiazine, sulfaisodimidine, sulfacetamide, sulfisoxazole, sulfasalazine, sulfadoxine and dichlorphenamide. One of the combination drugs available in this class is the sulfamethoxazole/trimethoprim combination which becomes bactericidal in action in contrast with the other sulfa drugs. Some of the key brands available in this class are Dapsone (diamino-diphenylsulfone) and Sepmax (sulfamethoxazole and trimethoprim) from GlaxoSmithKline plc; Blephamide(prednisolone and sulfacetamide) from Allergan, Inc. and Vasocidin (prednisolone and sulfacetamide) from Novartis AG.

Request for Sample Report: http://www.mrrse.com/sample/2005

Major growth drivers for the systemic antibiotic-sulfonamide combination market will include availability of large number of generics at affordable prices in emerging markets and increasing prevalence of various infectious diseases such as urinary tract and upper respiratory tract infections. These drivers are likely to push the volume sales of drugs of this class. Worldwide rise in elderly population is also expected to play a key role in driving the market growth as elderly populations is at high risk of developing various infections requiring systemic antibiotic-sulfonamide combination drugs for cure.

Global Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market: Geographical Dynamics

Geographically, the market for systemic antibiotic-sulfonamide combination pharmaceuticals has been segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). In North America and Europe, the market is characterized by market maturity and increasing penetration by generic manufacturers. Stringent regulatory guidelines pose a significant challenge before the growth of this market to some extent in these regions. However, the market may experience a significant growth on the introduction of new products during coming years. Asia-Pacific represents the most potential market for this segment and is expected to record the highest growth rate during the upcoming years. Some major factors expected to drive the systemic antibiotic-sulfonamide combination market growth in the region include, presence of large number of generic manufacturers in major Asian countries (especially in India and China), growing incidences of infectious diseases and emerging economies leading to increased purchasing power of the people belonging to this region. In addition, the region being a home for more than half of the world population is also likely to represent a large pool of patients with various infectious diseases that would consequently increase the uptake of sulfonamide class of drugs.

Global Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market: Competitive Landscape

Some of the major players engaged in the development, manufacturing and marketing of systemic antibiotic-sulfonamide combination drugs are GlaxoSmithKline plc, Allergan, Inc., Pfizer Ltd., Sanofi, Novartis AG, Bristol-Myers Squibb Company, Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and AstraZeneca plc. These players compete with each other in order to get competitive advantages over each others. In developing nations like India, China, Mexico and Brazil, they face intense competition from local manufactures that offer systemic antibiotic-sulfonamide combination drugs at relatively low prices.

Browse Full Report with TOC: http://www.mrrse.com/systemic-antibiotic-sulfonamide-combination-pharmaceuticals-market

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Follow Us on LinkedIn-https://www.linkedin.com/company/mrrse
Follow Us On Twitter-https://twitter.com/MRRSEmrrse

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Analysis of Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market - Industry Analysis, Size, Share, Growth, Trends and Forecast here

News-ID: 495172 • Views:

More Releases from Latest Research Report - MRRSE

Veterinary Radiography Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 - 2023
Veterinary Radiography Systems Market - Global Industry Analysis, Size, Share, G …
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Veterinary Radiography Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 - 2023”. Request For Sample Report@ http://www.mrrse.com/sample/2012 Veterinary Radiography Systems Market: Overview Animal radiography employs similar techniques used on humans as a tool to diagnose diseases and injuries. Veterinary radiography comprises of several imaging modalities such as CT, MRI, PET, X-rays and others similar and
Physician Dispensed Cosmeceuticals Global Market Industry Analysis Research reports and Forecast Growth 2016 - 2024
Physician Dispensed Cosmeceuticals Global Market Industry Analysis Research repo …
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Physician Dispensed Cosmeceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”. Request For Sample Report@ http://www.mrrse.com/sample/1960 The report analyzes the current and future prospects of the physician dispensed cosmeceuticals market across the globe for the forecast period from 2016 to 2024. The research is a combination of primary and secondary research. Primary research
Welding Consumables (Stick Electrode, Solid Wires, Flux-cored Wires, SAW Wires & Fluxes, and Others)Global Market Industry Analysis Research Report and Forecast 2014 - 2020
Welding Consumables (Stick Electrode, Solid Wires, Flux-cored Wires, SAW Wires & …
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Welding Consumables (Stick Electrode, Solid Wires, Flux-cored Wires, SAW Wires & Fluxes, and Others) Market for Automobile & Transportation, Building & Construction, Marine, and Other Applications - EMEA Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”. The welding industry comprises welding equipment, welding consumables and welding services. Welding consumables account for a significant share of
Wave and Tidal Energy Global Market Industry Analysis Research Report and Forecast 2016 - 2024
Wave and Tidal Energy Global Market Industry Analysis Research Report and Foreca …
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Wave and Tidal Energy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”. Wave and tidal energy are methods of harnessing energy of oceans for power generation. Countries across the world are increasingly looking to utilize these forms of renewable energy as these provide a constant and steady source of clean energy. Request For

All 5 Releases


More Releases for Combination

Advancements in Cancer Combination Therapy
Cancer combination therapy, which involves the use of multiple therapeutic agents, has revolutionized cancer treatment in recent years. This approach leverages the strengths of different therapies to enhance efficacy, reduce toxicity, and overcome drug resistance, leading to better patient outcomes.The concept of combination therapy is not new. It has been used successfully in treating infectious diseases and some chronic conditions. However, its application in cancer therapy has seen significant advancements
Combination Vaccines Market Green and Efficient: The Future of Immunization with …
Combination Vaccines Market to reach over USD 10.11 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Combination Vaccines Market Size, Share & Trends Analysis Report By Technology (Conjugate, Live, Inactivated), Age Group (Pediatric, Adult), Application (Diphtheria, Tetanus, & Pertussis (DTP), Polio, Hepatitis B, Influenza), End-use (Hospitals, Clinics), Region, Market Outlook And Industry Analysis
Combination of light and shade
Designer awning for glass canopies mesmerises with fantastic accentuated lighting Underglass awnings are perfect for patio roofs and conservatories. Because under a glass canopy, they have plenty of protection. One new model is the "markilux 679". It has clean lines in its design, provides plenty of shade and creates a beautiful interplay of light on the patio with its LED lights. Unlike above-glass awnings, underglass awnings are fixed under a glass canopy.
Combination of light and shade
Underglass awning by markilux combines clean design with effective LED technology The "markilux 679" is a new form of solar protection for patio roofs and conservatories. The awning has a modern cubic shape, offers plenty of shade and, with LED Lines controlled by an app, ensures an attractive interplay of light on both the cover and façade of the house. Underglass awnings are perfect for both patio roofs and conservatories. The cover,
Combination Hypertension Agents Market - Maximum Impact on Blood Pressure: Combi …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Combination Hypertension Agents Market. Combination Hypertension Agents Market: https://www.growthplusreports.com/report/combination-hypertension-agents-market/9169 The Combination Hypertension Agents Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Fixed-Dose Combination Drugs Market - Leading Innovation in Combination Drug Del …
Newark, New Castle, USA - new report, titled Fixed-Dose Combination Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Fixed-Dose Combination Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Fixed-Dose Combination Drugs market. The report offers an overview of